[ Price : $8.95]
FDA clears Cresilons Traumagel device that uses a plant-based technology to control moderate to severe bleeding at the point of ca...[ Price : $8.95]
FDA describes CDERs new state-of-the-art advanced manufacturing research facility.[ Price : $8.95]
FDA accepts for priority review an AstraZeneca supplemental BLA for Imfinzi (durvalumab) and its use in certain patients with limi...[ Price : $8.95]
FDA grants Wave Life Sciences a rare pediatric disease designation for WVE-N531 and its use in treating boys with Duchenne muscula...[ Price : $8.95]
FDA approves a Vericel supplemental BLA for NexoBrid (anacaulase-bcdb) for eschar removal in pediatric patients with deep partial-...[ Price : $8.95]
Two stakeholders respond to an FDA request for comments on the agencys recent listening session on advisory committees and their g...[ Price : $8.95]
Gardner Law says prescription drug manufacturers and marketers need to be sure their social media promotions can withstand FDA scr...[ Price : $8.95]
FDA gives accelerated approval to Gileads Livdelzi to treat some cases of primary biliary cholangitis.